Immunological tolerance inducer kit

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C426S601000, C426S656000

Reexamination Certificate

active

06221354

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to a method for preventing and treating crises of allergic reactions and immunological rejection reactions. Particularly, the present invention relates to a method for preventing and treating crises of allergic reactions, such as food allergy, pollen allergy, bee allergy, lacquer poisoning and the like, which are induced by ingestion or inhalation of antigens or percutaneous contact with antigens and immunological rejection reactions at the time of organ transplantation, which is effected based on the effective induction of immunological tolerance, and food and drugs using the method.
BACKGROUND OF THE INVENTION
A basic countermeasure to prevent recidivation of allergy is to avoid exposure to allergen. For example, in the case of food allergy, a countermeasure is taken by not eating allergen-containing food, refraining ingestion thereof or attenuating its allergenic property by thorough heating. In the case of pollen allergy, the most simple and effective countermeasure is to wear a mask or safety goggles or to refrain going out when drifting amount of pollen is large. These basic countermeasures are taken in daily life.
However, the object of these countermeasures is to prevent recidivation of allergic symptoms and not to perform fundamental treatment, although spontaneous remission may be expected in some cases.
In recent years, substitute milks for the mother's milk in which partially hydrolyzed peptide of milk protein is used as a nitrogen source have been put on the market to be used by familially allergic high risk babies for preventing crises of allergy. However, since there is no definite ground that the crises of milk allergy do not occur easily after changing to ordinary milk and dairy products, it is evident that these substitute milks are merely one of the choices to avoid antigens.
On the other hand, induction of the state of immunological tolerance is a therapeutic or preventive method in which its expected effects can be explained at least by its immunological mechanism. As examples of such a method, hyposensitization therapy and oral tolerance are known and have been carried out practically.
There are some reports in which percutaneous hyposensitization therapy is applied to treatments. Warner et al. disclose that a delayed asthmatic reaction induced by inhalant tick antigen was inhibited by hyposensitization therapy using a tick antigen preparation (Warner, J. O. et al., Lancet, 2:912 (1978)). Also, Norman et al. disclose that increase in the production of IgE antigen at a flowering time was inhibited by hyposensitization therapy using a urea-modified antigen IgE as a main antigen of ragweed pollen (Norman, P. S. et al., J. Allergy Clin. Immunol., 66:336 (1980)).
Patriarca et al. disclose oral hyposensitization therapy for treating food allergy (Patriarca, G. et al., eds., Food Allergy, Milano, Massom Italia, p.131 (1979)). Patriarca et al. have administered to patients who were allergic to milk, eggs or fruits, starting with a dose of 1 &mgr;g which was gradually increased thereafter by a factor of 1.5 for each step and finally succeeded in administering 10 g. Shenassa et al. disclose hyposensitization therapy of patients of peanut allergy (Shenassa, M. M. et al., J. Allergy Clin. Immunol., 75:177 (1985)). In the case of food allergy, however, the cause of the disease is an antigen which passed through the same route to begin with, and serious symptoms frequently occur even by an extremely small amount of the antigen, so that it seems to be difficult to carry out the treatment using a specific oral hyposensitization therapy without causing an allergic reaction because of a danger at least when un-treated antigen is used.
Recently, oral immunological tolerance is drawing attention as an effective method for treating autoimmune patients. Trentham et al. disclose the case of treating patients suffering from chronic rheumatoid arthritis (Trentham, D. E. et al., Science, 261:1727 (1993)). When each patient was allowed to ingest 0.1 to 0.5 mg of fowl II type collagen for 90 days in a total amount of 33 mg, the rheumatic symptoms were attenuated and 4 of 28 cases have completely recovered from the disease. Also, Weiner et al. disclose the clinical results of patients suffering from multiple sclerosis (Weiner, H. L. et al., Science, 259:1321 (1993)). A bovine myelin antigen containing myelin basic protein was administered to the patients with a dose of 300 mg a day for one year. Although significant effect was not found as a whole, an effect was observed in certain groups.
A living custom of Indians (Dakin, R., Am. J. Med. Sci., 4:98, (1829)) and lacquer artisans in relation to the prevention of lacquer poisoning is well known as a prior art means for inducing immunological tolerance for the purpose of prevention. They have learned from their ancestors that children who were forced to eat lacquer would hardly be poisoned with lacquer later, and this is still handed down by tradition.
Wells et al. have studied and reported the phenomenon of oral immunological tolerance for the first time as a science (Wells, H. G. et al., J. Infect. Dis., 8:66 (1991)). Wells et al. disclose that, when un-sensitized guinea pigs are allowed to ingest ovalbumin, an anaphylactic reaction cannot be induced using the antigen. In Hanson et al., an aqueous solution of ovalbumin was administered to mice of a highly ovalbumin-responding line by single and plural gastric administration and then the mice were immunized with the same antigen by intraperitoneal injection using aluminum hydroxide gel as the adjuvant (Hanson, D. G. et al., J. Immunol., 123:2337 (1979)). Hanson et al. disclose that, as a result, the production of serum anti-ovalbumin antibodies and reagin antibodies was inhibited almost completely.
Antigens which induce oral immunological tolerance are not limited to food antigens. Aramaki et al. disclose that, when an extract of ragweed pollen was orally administered to mice and then the same antigen was used in booster together with an adjuvant, production of specific IgE antibodies was inhibited (Aramaki, Y. et al., Immunol. Lett., 40:21 (1994)). Ishii et al. disclose that, when guinea pigs were immunized with a tick extract by parenteral administration using aluminum hydroxide as an adjuvant and then the extract was orally administered for 1 week, an oral hyposensitization effect was observed, because threshold value of a tick inhalation induction test and threshold value of histamine inhalation were increased, thereby discussing that oral hyposensitization therapy would be effective also upon pollen allergy (Ishii, A. et al., Int. Arch. Allergy Appl. Immunol., 94:288 (1991)).
It is said that aptness to cause induction of oral immunization is different depending on kinds of animals. According to reports so far published, it is considered that ruminants, rabbits and guinea pigs are resistant to the induction, and rodents such as mice, rats and the like are sensitive to the induction. Even in the case of human, a possibility of establishing oral immunological tolerance has been suggested by Korenblatt et al. and Lowney (Korenblatt, P. E. et al., J. Allergy, 41:226 (1968); Lowney, E. D., J. Invest. Dermatol., 512:411 (1968)). Recently, Husby et al. have asked a volunteer to ingest 0.5 g of hemocyanin of a shellfish, Macroschisma siensis, a protein which is not generally taken by human, and subcutaneous immunization was carried out thereafter, and suggested that immunological tolerance could be induced at least in T lymphocytes (Husby, S. et al., J. Immunol., 152:4663 (1994)).
In the above cases, all of the antigens are used in the form of aqueous solution as if a coincidence, but the reason for this is not described. Since comparison of these antigens with test groups in which other components are added is not described, it is evident that such an administration in the form of aqueous solution is not selected on purpose.
It is known in general that antigens having stronger property to induce immune response also have stronger

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunological tolerance inducer kit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunological tolerance inducer kit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological tolerance inducer kit will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2484030

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.